OpenAlex
PricingAboutJobs
Log inGet started
Work

Novel Pathways in the Treatment of Major Depression: Focus on the Glutamatergic System

HTML

Year: 2019
Type: review
Source: Current Pharmaceutical Design
DOI: 10.2174/1381612825666190312102444
Authors: Carmine Tomasetti, Chiara Montemitro, Annastasia L.C. Fiengo, Cristina Santone, Laura Orsolini, Alessandro Valchera, Alessandro Carano, Maurizio Pompili, Gianluca Serafini, Giampaolo Perna, Federica Vellante, Giovanni Martinotti, Massimo D. Giannantonio, Yong-Ku Kim, Marco D. Nicola, Antonello Bellomo, Antonio Ventriglio, Michele Fornaro, Domenico D. Berardis
Institutions: Azienda Ospedaliera Sant'Andrea, Sapienza University of Rome, Ospedale Policlinico San Martino, University of Genoa, Hermanas Hospitalarias del Sagrado Corazón de Jesús, Korea University, Università Cattolica del Sacro Cuore, University of Foggia, Federico II University Hospital, University of Naples Federico II
Language: English

Topic: Treatment of Major Depression
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: major depressive disorder, glutamatergic system, glutamate, depression pathophysiology, ketamine, monoamine hypothesis, treatment-resistant depression, antidepressant treatment
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2922005496
FWCI: 0.618
Cites: 75
Cited by: 52
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security